Loading viewer...
earnings
Format: PDF earnings
Ginkgo Bioworks' Q1 2024 business review covering operational updates, financial outlook, and strategic initiatives including site consolidation and workforce adjustments. The presentation details progress toward adjusted EBITDA breakeven, Biofab1 opening timeline, and expansion of biodefense capabilities through the bioradar network and AI tools development.
earnings
9 Pages
General Motors
Infineon FY2020 Q4 Investor Update
earningsearnings
76 Pages
Infineon Technologies AG
Ares Capital Corporation Q2 2016 Earnings Presentation
earningsearnings
25 Pages
ARES Capital Corporation